New Delhi, February 08, 2018: The organization had posted a benefit after assessment of Rs 194.9 crore for the comparing time of the past monetary, Natco Pharma said in a BSE documenting.
Medication firm Natco Pharma today detailed a 11.54 for each penny ascend in its united benefit after assessment at Rs 217.4 crore for the quarter finished December 2017.
The organization had posted a benefit after assessment of Rs 194.9 crore for the relating time of the past monetary, Natco Pharma said in a BSE recording.
Solidified aggregate incomes of the organization remained at Rs 573.6 crore for the quarter under thought against Rs 685.1 crore in a similar period a year prior.
The organization in a different recording stated, its board has announced second interval profit of Rs 7 on every value offer of Rs 2 for the year 2017-18. Offers of Natco Pharma were exchanging 1.05 for every penny down at Rs 903.70 for every scrip on BSE.
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…
- This specialized division empowers patients with neurological disorders to reclaim their mobility through a…